These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1766524)

  • 1. Effect of low doses of recombinant human erythropoietin on the anemia in hemodialyzed patients.
    Okada K; Takahashi S
    Nephron; 1991; 59(4):689-90. PubMed ID: 1766524
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
    Sobota JT
    Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-dose recombinant human erythropoietin in dialysis patients living at high altitude.
    Hussein MM; Bakir N; Roujouleh H
    Nephrol Dial Transplant; 1992; 7(2):173-4. PubMed ID: 1314980
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of the good effect of low doses of erythropoietin].
    Shostka GD; Dobronravov VA; Vasil'ev AN
    Urol Nefrol (Mosk); 1991; (5):74-5. PubMed ID: 1755131
    [No Abstract]   [Full Text] [Related]  

  • 5. [Erythropoietin in renal anemia].
    Peña Amaro MP; García López J; Camacho Romera M
    Rev Enferm; 1992 Mar; 15(163):67-70. PubMed ID: 1565973
    [No Abstract]   [Full Text] [Related]  

  • 6. Managing anemia in dialysis patients: hemoglobin cycling and overshoot.
    Singh AK; Milford E; Fishbane S; Keithi-Reddy SR
    Kidney Int; 2008 Sep; 74(5):679-83. PubMed ID: 18337717
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of parathyroidectomy on hematocrit and erythropoietin dose in patients on hemodialysis.
    Rault R; Magnone M
    ASAIO J; 1996; 42(5):M901-3. PubMed ID: 8945016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of anemia with low-dose recombinant human erythropoietin.
    Aronoff GR; Duff DR; Sloan RS; Brier ME; Maurice B; Erickson B; Golper TA
    Am J Nephrol; 1990; 10 Suppl 2():40-3. PubMed ID: 2260617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with recombinant human erythropoietin in patients with aluminum overload and hyperparathyroidism.
    Grützmacher P; Ehmer B; Limbach J; Messinger D; Kulbe KD; Scigalla P
    Blood Purif; 1990; 8(5):279-84. PubMed ID: 2091687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocytotoxic panel reactive antibodies in hemodialyzed patients treated with recombinant human erythropoietin.
    Aunsholt NA; Steffensen G; Povlsen JV; Ahlbom G
    Nephron; 1991; 59(3):499. PubMed ID: 1758547
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of erythropoietin in patients with chronic renal insufficiency and in hemodialysis].
    Cuero CJ; Pérez Guardia E; de Rivera C
    Rev Med Panama; 1996; 21(1-2):55-9. PubMed ID: 8966240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nandrolone decanoate on the anemia of chronic hemodialysis patients.
    Buchwald D; Argyres S; Easterling RE; Oelshlegel FJ; Brewer GJ; Schoomaker EB; Abbrecht PH; Williams GW; Weller JM
    Nephron; 1977; 18(4):232-8. PubMed ID: 323739
    [No Abstract]   [Full Text] [Related]  

  • 13. Subcutaneous erythropoietin in the treatment of renal anaemia.
    Drinovec J; Varl J
    Przegl Lek; 1992; 49(1-2):38-40. PubMed ID: 1455004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of recombinant human erythropoietin on interleukin-1 beta and interleukin-6 in patients on maintenance hemodialysis.
    Sayinalp N; Erdem Y; Haznedaroğlu IC; Dündar S; Cağlar S; Kirazli S
    Clin Nephrol; 1995 Dec; 44(6):404. PubMed ID: 8719556
    [No Abstract]   [Full Text] [Related]  

  • 15. [Low doses of recombinant erythropoietin in the treatment of renal anemia in patients on chronic hemodialysis and ambulatory peritoneal dialysis].
    Lashutin SV; Nikolaev AIu; Ermolenko VM; Shutov EV; Bezruk VG; Ivashchenko MA
    Ter Arkh; 1999; 71(6):61-3. PubMed ID: 10420460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Erythropoietin, blood viscosity and hypertension in chronic kidney failure].
    Schaefer RM; Heidland A
    Dtsch Med Wochenschr; 1989 Jun; 114(26):1046-9. PubMed ID: 2661190
    [No Abstract]   [Full Text] [Related]  

  • 17. Good response of endogenous erythropoietin to blood loss in persistently improving renal anemia after discontinuation of erythropoietin treatment.
    Yabana M; Ikeda Y; Kihara M; Kurita K; Toya Y; Tamura K; Takagi N; Onishi T; Umemura S
    Nephron; 1999 Jan; 81(1):111-2. PubMed ID: 9884433
    [No Abstract]   [Full Text] [Related]  

  • 18. [Improvement of hemorheologic parameters in hemodialyzed patients treated with human recombinant erythropoietin].
    Delamaire M; Durand F; Hamel D; Joyeux V; Lepogamp P; Genetet B
    J Mal Vasc; 1991; 16(3):289-94. PubMed ID: 1940657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of hemodialysis anemia is associated with significant increase in serum concentration of IGF-I in patients treated with erythropoietin: a randomized controlled study.
    Sheashaa HA; Khalil A; Aarman MM; El-Shahat FB; Selim A; El-Gawad SS
    Int Urol Nephrol; 2005; 37(1):153-8. PubMed ID: 16132779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of angiotensin-converting enzyme inhibitors on anemia in hemodialyzed patients.
    Teruel JL; Fernandez Juarez G; Marcen R; Nogueira J; Ortuño J
    Nephron; 1996; 73(1):113. PubMed ID: 8742977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.